| 000 | 01894 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515201141.0 | ||
| 264 | 0 | _c20100413 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.109.160416 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoh, Yung-Hua | |
| 245 | 0 | 0 |
_aExtracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cMar 2010 |
||
| 300 |
_a940-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCeruletide _xpharmacology |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNF-kappa B _xphysiology |
| 650 | 0 | 4 |
_aPancreas _xcytology |
| 650 | 0 | 4 |
_aPancreatitis _xmetabolism |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProtein Precursors _xbiosynthesis |
| 650 | 0 | 4 |
_aReceptor, Cholecystokinin A _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-1 _xbiosynthesis |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSubstance P _xbiosynthesis |
| 650 | 0 | 4 |
_aTachykinins _xbiosynthesis |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xphysiology |
| 700 | 1 | _aTamizhselvi, Ramasamy | |
| 700 | 1 | _aBhatia, Madhav | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 332 _gno. 3 _gp. 940-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.109.160416 _zAvailable from publisher's website |
| 999 |
_c19389378 _d19389378 |
||